The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat ...

Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small ...

A recent study published in Cell reveals that the repeated DNA sequence that leads to Huntington’s disease (HD) expands ...

People genetically susceptible to Huntington's disease often see their movement, mood, and cognition decline slowly over time.

Researchers at Tufts University revealed a possible molecular mechanism explaining how the DNA repeats are broken and then expanded in the Huntington’s disease gene, pointing to a component of the ...

Researchers have made a major breakthrough in our understanding of Huntington's disease. This genetic disorder has long been ...

Scientists are unraveling the mystery of what triggers Huntington's disease, a devastating and fatal hereditary disorder that ...

Huntington's disease is a hereditary disorder caused by a genetic mutation in the HTT gene, leading to progressive brain cell ...

Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen approximately twenty years before a clinical motor diagnosis in people with Huntington's ...

Approximately 23 years before a clinical diagnosis, CSF analysis showed very early signs of neurodegeneration with elevated ...

Scientists have discovered a surprising mechanism by which the inherited genetic mutation known to cause Huntington's disease leads to the death of brain cells. The findings change the understanding ...